ASXL1 and myelodysplastic syndrome: Additionally, patients with ASXL1 frameshift mutations had a worse prognosis in MDS‐LB patients (p = 0.043), indicating the impact of ASXL1 mutation types on prognostic evaluation in MDS [45].